Post-COVID-19 Investigations and Healthcare Fraud Guide

This guide addresses the implications of post-COVID-19 investigations and healthcare fraud, focusing on the challenges faced by healthcare providers in the wake of federal funding and scrutiny. It outlines the potential for increased federal investigations into alleged provider misconduct as the pandemic subsides, emphasizing the need for compliance with the False Claims Act (FCA). The document discusses the historical context of federal oversight during national crises and highlights the specific focus on healthcare, including the National Nursing Home Initiative aimed at protecting vulnerable populations. Additionally, it details the complexities surrounding waivers for Medicaid, Medicare, and CHIP, stressing the importance of understanding which requirements are waived and which remain in effect. Healthcare providers are encouraged to remain agile, document their decision-making processes, and seek authoritative guidance to navigate the evolving landscape of regulations and compliance effectively.